Careers

ENG

CellCarta’s Capabilities

Scientists working across CellCarta laboratories delivering integrated biomarker capabilities for complex clinical programs

Built for Complexity

The most demanding programs rarely fit into a single modality. CellCarta’s expertise and capabilities are built to span tissue, gene, protein, and immune response without compromising quality or continuity.

25+ Years of expertise

8 Global facilities

750+ Employees

Our Scientific Capabilities

CellCarta scientist developing multi-platform biomarker strategies across discovery and clinical development stages

Biomarker Solutions

Multi-platform biomarker strategies from discovery through clinical development.

Genomics

Proven and emerging molecular platforms for clinical sample analysis and reporting.

Sequencing Services Digital PCR (dPCR) Quantitative PCR (qPCR) Assays by Mutations

Histopathologist performing multiplexed tissue analysis with AI-powered image analysis at CellCarta

Histopathology

Multiplexed tissue analysis with in-house pathologists and AI-powered image analysis.

Digital Pathology IF and IHC ISH Spatial Biology

Scientist conducting multiplex immune response monitoring assays supporting clinical trial biomarker programs

Immune Monitoring

Multiplex assays for immune response monitoring across all clinical trial phases.

Basophil Activation Test (BAT) Cell Enumeration Cell Proliferation Cellular Phenotyping

Immunoassay Platform

Validated immunoassay platforms for precise biomarker quantification and clinical testing.

Ella™ Olink PEA FluoroSpot and ELIspot Hybrid LBA/LC-MS

Proteomics

Fully integrated MS platforms for large-scale discovery and bioanalytical testing.

Unbiased Discovery Biomarker Quantification

Why CellCarta

We deliver what complex preclinical and clinical programs demand: depth, rigor, and consistency.

Learn more about us Explore our global network

Deep Scientific Rigor

Integrated Multi-Modal Capabilities

Global Execution

Complex Biomarker Expertise

High-Touch Collaboration

Learn more about us Explore our global network

What our clients say

Your RNAseq services are best in class and delivered lower duplication rates and much better unique read coverage.

Biopharma Partner

I turn to CellCarta for my most challenging samples and assay needs. Their mass spec team has a strong reputation for delivering robust, reliable data on tight timelines using advanced technologies for difficult analytical challenges.

Biopharma Partner

Case Studies

Jun 15, 2026

Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq

Videos

Sep 2, 2025

Poster Video: Induction of an effective immune response is an essential element of cancer immunotherapy

Blog

Nov 25, 2025

TBNK Panels: How To Select the Optimal One

No matter where your science leads, CellCarta has the platforms, the expertise, and the quality infrastructure to meet it. Let's discuss how we can best support your program.